346171 <common-name>N-[(e)-(5-bromo-2-fluorophenyl)methylideneamino]-2-[[5-(4-tert-butylphenyl)-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]acetamide</common-name> <description>N-[(e)-(5-bromo-2-fluorophenyl)methylideneamino]-2-[[5-(4-tert-butylphenyl)-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]acetamide is a chemical compound with the formula C27H25BrFN5OS. With an average molecular weight of 566.50 g/mol, N-[(e)-(5-bromo-2-fluorophenyl)methylideneamino]-2-[[5-(4-tert-butylphenyl)-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]acetamide is a heavy molecule.</description> <cas>303102-44-5</cas> <pubchem-id>6863128</pubchem-id> <chemical-formula>C27H25BrFN5OS</chemical-formula> <weight>566.5</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T09:32:09Z</created-at> <updated-at type="dateTime">2026-08-31T09:32:09Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC(C)(C)C1=CC=C(C=C1)C2=NN=C(N2C3=CC=CC=C3)SCC(=O)NN=CC4=C(C=CC(=C4)Br)F</moldb-smiles> <moldb-formula>C27H25BrFN5OS</moldb-formula> <moldb-inchi>InChI=1S/C27H25BrFN5OS/c1-27(2,3)20-11-9-18(10-12-20)25-32-33-26(34(25)22-7-5-4-6-8-22)36-17-24(35)31-30-16-19-15-21(28)13-14-23(19)29/h4-16H,17H2,1-3H3,(H,31,35)/b30-16+</moldb-inchi> <moldb-inchikey>FMWSJUYNULINED-OKCVXOCRSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">565.09472</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>7</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM342064</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>N-[(e)-(5-bromo-2-fluorophenyl)methylideneamino]-2-[[5-(4-tert-butylphenyl)-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]acetamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Azoles</klass> <subklass>Triazoles</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0296524</sync-id> <structure-inchikey>FMWSJUYNULINED-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>404000200000800000002800000000000000000000400080000000000000000000000002000004008000002084800000000000000000000000200000000000000000000000000000000000000020400000000210000004800010000200000000010000000000000080100000800400080100000040000000000000000000004040000000800000000000000084880800010100000000000000000000000000000000001000000000080000000040000000400000000000002c00000000000800004000000000000100000000400000000000002000000200000000000000000040008000001048000000000400800000810000000040000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAkAAAAJwAAAIABBgBgAAAAAQMGACAAAAAE BgBgAAAAAQMGAGAAAAABAwZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBkAo AAAAAwQGQGgAAAADAwEGQGgAAAADAwEGQCgAAAADBAdAKAAAAAMDB0AoAAAA AwMGQCgAAAADBAdAKAAAAAMDBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEG QGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEQACAAAAACBgBgAAAAAgIGACgA AAADBAgAKAAAAAMCBwBoAAAAAwIBBwAoAAAAAwMGAGgAAAADAwEGQCgAAAAD BAZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBkAoAAAAAwQGQGgAAAADAwEj ACAAAAABCQAgAAAAAQsAAQABAgABAwABBAAEBWgMBQZoDAYHaAwHCGgMCAlo DAcKIAoLaAwLDGgMDA1oDA0OaAwODyAPEGgMEBFoDBESaAwSE2gMExRoDA0V ABUWABYXABcYKAIXGSAZGiAaGygCGxwgHB1oDB0eaAweH2gMHyBoDCAhaAwg IgAdIwAJBGgMDgpoDBQPaAwhHGgMQgQAAAAGBAkIBwYFBQsKDg0MBhAREhMU DwYdHh8gIRwXBAAAAAAAAAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:44:59Z</structure-indexed-at> </compound>